New book by Larry Connors Click here Improve your trading - See how
In addition to other recent positive developments across the life sciences industries, yesterday's call from Eli Lilly Chief Executive Officer John Lechleiter for the industry to "reinvent innovation" (http://www.pharmatimes.com/WorldNews/article.aspx?id=16843&src=EWorldNews) is another towering guidepost for all companies to continue producing new medicines and treatments and to better communicate the benefits that the industry brings to society. CEI's research over the last decade has shown swings in both the industry's approach to driving new drug development and communicating the value of that work to the world's health. As regulatory pressure has increased because of overall healthcare changes, the industry has clarified and strengthened its message. While progress has been made in educating various stakeholders, including physicians, patients and payers, much work remains to be done. "No other industry has to balance the massive dual challenges of public demand for rapid innovation and sometimes 'miracle' cures with such incredibly strict regulatory oversight," said Jason Richardson, president of CEI. "Of course, both of those demands are understandable -- people want to see the fruits of science, particularly when a loved one's health is at stake, but they also want the government and industry's assurances that these advances are not going to do more harm than good." Across various therapeutic areas (http://www.cuttingedgeinfo.com/reports/forecasting-market-research.php), companies are making advances into ever more complicated science. And every company is working to make its clinical development, medical affairs, patient education and lifecycle management programs more productive, both for shareholder value and for the efficiency of the overall healthcare system (http://www.cuttingedgeinfo.com ). "Pharmaceuticals and Biotechnology have faced an especially tough wave of specific issues that have clouded their picture," said Adam Bianchi, chief operating officer of CEI. "Some of that externally driven cloud has lifted, and now companies are plotting the strategies that will really let them clear the smoke and blaze productive paths forward to 2011, 2015, and beyond." For more information, please contact: Stephanie Swanson 919-433-0212 Email Contact SOURCE: Cutting Edge Information http://www2.marketwire.com/mw/emailprcntct?id=95E62CC7BE8AA871 For full details on Eli Lilly & Company (LLY) click here. Eli Lilly & Company (LLY) has Short Term PowerRatings of 5. Details on Eli Lilly & Company (LLY) Short Term PowerRatings is available at This Link.
Email Print Archives Feedback Email Article Link
Close X
Related News [LLY]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
